Rebekah Moan[email protected]Clinical NewsMedical groups urge endovascular training for strokeMultiple interventional radiology societies have committed to providing necessary stroke training to interventional radiologists to alleviate the shortage of physicians trained in endovascular stroke therapies.October 29, 2018AIACR DSI releases use cases to speed up AI adoptionThe American College of Radiology Data Science Institute (ACR DSI) has released a series of standardized artificial intelligence (AI) use cases that will accelerate the adoption of AI for medical imaging.October 26, 2018Radiation Oncology/TherapyASTRO: SABR is effective for oligometastatic cancersStereotactic ablative radiotherapy (SABR) can greatly increase how long oligometastatic patients survive and doubles how long they live without cancer, according to new research presented at this week's American Society for Radiation Oncology (ASTRO) meeting.October 22, 2018BreastDBT spots 34% more breast cancers than mammographyOne-view digital breast tomosynthesis (DBT) detects 34% more breast cancers than traditional mammography -- with a majority of the detected tumors proving to be invasive cancers, according to a large clinical study in Sweden.October 16, 2018EconomicsCancer death disparities linked to poverty, lifestyleYale researchers have found that disparities in cancer death rates are linked to poverty and lifestyle factors across the U.S. The factors may provide public health experts with specific targets for potentially reducing such disparities, the researchers said.October 8, 2018Industry NewsGE replaces CEO Flannery with CulpIndustrial conglomerate GE announced on Monday that it has booted CEO John Flannery just over a year into his tenure and replaced him with turnaround expert Lawrence (Larry) Culp Jr. in a unanimous vote effective immediately.September 30, 2018BreastPatient navigators help black women with mammogramsBlack women who face barriers to healthcare are more likely to get follow-up mammograms if patient navigators are available to assist them, according to a study published on September 24 in the journal Cancer.September 24, 2018UltrasoundDrop ultrasound contrast agent warning, society saysThe International Contrast Ultrasound Society (ICUS) has filed a petition with the U.S. Food and Drug Administration urging the agency to remove boxed warnings from ultrasound contrast agents. ICUS believes the warnings are obsolete in light of clinical experience and recently released data on the safety of the agents.September 17, 2018BreastStudy claims breast screening does not reduce mortalityThe findings of a new Danish-Norwegian study are reviving the claim that the recent drop in breast cancer mortality is not due to mammography screening but rather the result of improved treatment. The authors assert it's time to consider alternatives to mammography screening -- such as breast palpation by physicians.September 12, 2018AIRSNA launches AI challenge to detect pneumonia on x-raysThe RSNA has launched its second annual machine-learning challenge: The RSNA Pneumonia Detection Challenge invites teams to develop artificial intelligence (AI) algorithms to identify and localize pneumonia in chest x-rays, with top submissions to be recognized at the RSNA 2018 meeting.August 27, 2018Page 1 of 10Next PageTop StoriesHomeSNMMI: PET reveals new brain activity in multiple sclerosisUnderstanding how and where certain brain connections are lost can help explain the symptoms patients experience.SNMMI 2026SNMMI: New PET platform guides real-time bone cancer margin assessmentWomens ImagingAI approach could improve DBT efficiencySNMMI 2026SNMMI: Incoming president talks meeting highlights, previews next yearSNMMI 2026SNMMI: Biomarkers predict I-131 response in obese thyroid cancer patients
![(A-C) Representative whole-body maximum-intensity projection images and regional fused PET/CT images from three histologically confirmed osteosarcoma patients who underwent paired [68Ga]Ga-B7-H3-BCH PET/CT and 18F-FDGE PET/CT within seven days. (D) Multimodal imaging evaluation of Patient Three, including x-ray, MRI (T2-weighted imaging, T2WI), CT, and B7-H3 PET/CT.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/05/mei.XUQJWkpAJI.jpg?auto=format%2Ccompress&fit=crop&h=167&q=70&w=250)
![(A-C) Representative whole-body maximum-intensity projection images and regional fused PET/CT images from three histologically confirmed osteosarcoma patients who underwent paired [68Ga]Ga-B7-H3-BCH PET/CT and 18F-FDGE PET/CT within seven days. (D) Multimodal imaging evaluation of Patient Three, including x-ray, MRI (T2-weighted imaging, T2WI), CT, and B7-H3 PET/CT.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/05/mei.XUQJWkpAJI.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
![RET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding peptide tracer [⁶⁸Ga]Ga-DOTA-RET-L7 in a neuroendocrine prostate cancer (NEPC) model, supporting highly specific, high-contrast detection.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/05/screenshot-2026-05-27-205827.278Ys6PYU3.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
